Cancer Research, Statistics, and Treatment (Jan 2024)

Gefitinib triumphs: Long-term advantages over chemotherapy in the treatment of EGFR mutant lung cancer

  • Rakesh Pinninti

DOI
https://doi.org/10.4103/crst.crst_400_23
Journal volume & issue
Vol. 7, no. 1
pp. 107 – 109

Abstract

Read online

No abstracts available.